Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Inhaled Medications01:23

Inhaled Medications

764
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
764
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

219
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
219
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

185
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
185
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

322
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
322
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

212
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
212

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Cardiac rehabilitation after myocardial infarction: Insights into participation rates and predictors, sex differences and outcomes from a Dutch general hospital.

American heart journal plus : cardiology research and practice·2026
Same author

Implementation of a deprescribing guideline by community pharmacists: A focus group study.

Exploratory research in clinical and social pharmacy·2026
Same author

Access to clinical data for direct oral anticoagulant prescriptions in community pharmacy and implications for medication optimisation: a mixed-methods study.

International journal of clinical pharmacy·2026
Same author

Integration of pharmacy practice research in the Dutch pharmacy education continuum.

The International journal of pharmacy practice·2026
Same author

Factors Associated With Concurrent Benzodiazepine and Opioid Use Following Total Hip and Knee Arthroplasty: A Nationwide Cohort Study.

Pharmacoepidemiology and drug safety·2026
Same author

Heart failure patients with reduced or mildly reduced ejection fraction: baseline characteristics of the low-dose digoxin outcome DECISION trial.

European journal of heart failure·2026

関連する実験動画

Updated: Jan 23, 2026

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells
09:20

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells

Published on: July 23, 2010

16.3K

服薬アドヒアランス

Eline Harding1, Charlotte de Fouw1, Marcel L Bouvy2

  • 1Diakonessenhuis Utrecht, afd. Cardiologie, Utrecht.

Nederlands tijdschrift voor geneeskunde
|January 22, 2026
PubMed
まとめ

服薬アドヒアランスは治療成功に不可欠であり、患者の30〜50%がさまざまな理由で苦労している。アドヒアランスの向上には、教育、サポート、デジタルツールなどの個別化された戦略が含まれ、信頼とコミュニケーションが強調される。

科学分野:

  • ヘルスケアアドヒアランス研究; 患者コンプライアンス研究; 治療転帰の最適化
キーワード:
服薬アドヒアランス治療成功患者コンプライアンス個別化された戦略信頼コミュニケーション

さらに関連する動画

Clonogenic Assay: Adherent Cells
05:30

Clonogenic Assay: Adherent Cells

Published on: March 13, 2011

49.2K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.1K

関連する実験動画

Last Updated: Jan 23, 2026

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells
09:20

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells

Published on: July 23, 2010

16.3K
Clonogenic Assay: Adherent Cells
05:30

Clonogenic Assay: Adherent Cells

Published on: March 13, 2011

49.2K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.1K

背景:

  • 服薬アドヒアランスは、患者が合意された治療計画に従うことと定義される。アドヒアランスの低下は患者の30〜50%に影響し、意図的または実際的な障壁に起因する。慢性疾患、認知機能の問題、疾患理解の不足は、アドヒアランス低下のリスクを高める。

主な方法:

  • 服薬アドヒアランスに関する文献レビュー。アドヒアランス低下の原因となる要因の分析。アドヒアランス改善に成功した戦略の統合。

結論:

  • 服薬アドヒアランスの向上には、患者中心のアプローチが必要である。オープンなコミュニケーション、信頼、学際的な協力が不可欠である。個別化された戦略は、長期的な治療効果と患者の転帰を改善するための鍵である。